All modalities of treatment for warts can be painful and may be associated with scarring and frequent recurrences. In addition, destructive modalities are not suitable for the treatment of multiple and refractory warts as they clear only treated lesions and not the distant ones. Hence, to overcome these shortcomings, immunotherapy is being tried widely for the treatment of warts over the last few years. It acts on the basic principle of enhancing cell-mediated immunity for the clearance of warts. Various antigens have been tried including measles, mumps, rubella (MMR); tuberculin purified protein derivative (PPD); Mycobacterium w vaccine and Candida antigen. However the cost of these treatment modalities is high. In a developing country, the affordability of the treatment plays a very important role in managing the patient with the disease. vitamin D comes up as one of the most affordable options for immunotherapy of the same.